Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (2) | Back to Search
Valproic Acid Showed Antitumor Activity through Nuclear KIT-NFKBIB-NFKB Feedback in Imatinib-Resistant Gastrointestinal Stromal Tumors
- In: Poster presentation
- At: Buenos Aires (Argentina) (2016)
- Type: Poster
- Poster code: POS-TRI-005
- By: HSUEH, Yuan-Shuo (National Health Research Institutes, National Institute of Cancer Research, Tainan, China Taiwan)
- Co-author(s): Yuan-Shuo Hsueh:National Institute of Cancer Research,National Health Research Institutes,Tainan,Taiwan, Province of China|Hui Hua Chang:Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine,National Cheng Kung University,Tainan,Taiwan, Province of China|Chien-Feng Li:Department of Pathology,Chi-Mei Foundation Medical Center,Tainan,Taiwan, Province of China;National Institute of Cancer Research,National Health Research Institutes,Tainan,Taiwan, Province of China;Department of Biotechnology,Southern Taiwan University of Science and Technology,Tainan,Taiwan, Province of China|Yan-Shen Shan:Institute of Clinical Medicine, College of Medicine,National Cheng Kung University,Tainan,Taiwan, Province of China;Department of Surgery,National Cheng Kung University Hospital,Tainan,Taiwan, Province of China|Jonathan A Fletcher:Department of Pathology,Brigham and Women’s Hospital and Harvard Medical School,Boston,United States|Li-Tzong Chen:National Institute of Cancer Research,National Health Research Institutes,Tainan,Taiwan, Province of China;Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine,National Cheng Kung University,Tainan,Taiwan, Province of China;Department of Internal Medicine,National Cheng Kung University Hospital,Tainan,Taiwan, Province of China;Department of Internal Medicine,Kaohsiung Medical University Hospital, Kaohsiung,Taiwan, Province of China
- Abstract:
Gastrointestinal stromal tumor (GIST) is a dominantly mutant KIT-driven tumor. Drug resistance is an increasing clinical issue after long-term treatment.
In this study, two imatinib-resistant GIST cell lines, GIST48 and GIST430, were used as a model.
Herein, we first showed that KIT is distributed both in the cytoplasm and nucleus in GIST cells.
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023